OTC : IHICY
-$0.02 (-0.12%)
| Source | Headline |
|---|---|
|
IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action
I reiterate a Hold rating on the iShares US Medical Devices ETF despite its 20% YTD decline and ongoing technical weakness. IHI's valuation is reasonable but not compelling, with a P/E of 18.8x and a 10.3% long-term EPS growth rate. The ETF is highly concentrated, with its top 10 holdings accounting for 75% of the portfolio and a low dividend yield at 0.45%. seekingalpha.com - 2026-06-14 09:00:28 |